PT Charlie Hospital Semarang Tbk
PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia. The company offers medical services and support, inpatient, and medical check-up services, as well as operates wellness center. The company was founded in 2019 and is based in Kendal, Indonesia. PT Charlie Hospital Semarang Tbk is a subsidiary of PT Wahyu Agung.
PT Charlie Hospital Semarang Tbk (RSCH) - Total Liabilities
Latest total liabilities as of September 2025: Rp144.88 Billion IDR
Based on the latest financial reports, PT Charlie Hospital Semarang Tbk (RSCH) has total liabilities worth Rp144.88 Billion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PT Charlie Hospital Semarang Tbk - Total Liabilities Trend (2022–2024)
This chart illustrates how PT Charlie Hospital Semarang Tbk's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PT Charlie Hospital Semarang Tbk Competitors by Total Liabilities
The table below lists competitors of PT Charlie Hospital Semarang Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seneca Financial Corp
PINK:SNNF
|
USA | $292.04 Million |
|
Silver Grant International Holdings Group Limited
F:YSG
|
Germany | €4.42 Billion |
|
Workhorse Group Inc
NASDAQ:WKHS
|
USA | $84.67 Million |
|
Y. T. Realty Group Limited
PINK:YTRGF
|
USA | $18.11 Billion |
|
Arthavest Tbk
JK:ARTA
|
Indonesia | Rp22.61 Billion |
|
LiqTech International Inc
NASDAQ:LIQT
|
USA | $17.52 Million |
|
IT Link
PA:ALITL
|
France | €31.36 Million |
Liability Composition Analysis (2022–2024)
This chart breaks down PT Charlie Hospital Semarang Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PT Charlie Hospital Semarang Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PT Charlie Hospital Semarang Tbk (2022–2024)
The table below shows the annual total liabilities of PT Charlie Hospital Semarang Tbk from 2022 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp45.51 Billion | +1045.65% |
| 2023-12-31 | Rp3.97 Billion | -92.56% |
| 2022-12-31 | Rp53.43 Billion | -- |